ClusterOS Diagnostic Profile
Greater Manchester Health
Greater Manchester Health draws £1.51bn of UKRI lead-led funding across 5,705 grants, anchored by Manchester (40%), with Medicines Discovery Catapult and Siemens on the industrial side. 52 Companies House-traced spin-outs translate to £29m UKRI per spin-out.
The cluster shows medium-confidence "Re-proving instead of narrowing" and "Stabilising around incumbents" behaviour — repeated infrastructure commitments reinforce incumbent positions rather than redirecting capability toward new anchors or sub-domain specialisms.
Tap diagram to enlarge
Same data examined through five diagnostic lenses — Pipeline, Leverage, Triple Helix, Throughput, Collaboration. The interactive diagnostic is currently in private preview.
Sources: UKRI Gateway to Research (grants, outcomes); OpenAlex (publications); Companies House (spin-out lifecycle); DSIT (cluster mapping); Public investment data. Snapshot May 2026.
Stabilisation stacks · Why single interventions fail
Intermediaries produce narrative about their facilitation role; narrative legitimises intermediary existence and funding; uncertainty about direct coupling absorbed by narrative rather than demonstration.
"If one successful outcome from the Manchester Academic Health Science Centre partnership (P001, P002, P004: direct partnership between UoM, Christie, MFT) were documented and disseminated as a case study explicitly noting that the outcome was achieved through direct partnership without Health Innovation Manchester intermediation, it might reduce the system's ability to absorb uncertainty signals about direct coupling through intermediary-produced narrative (S7)."
Leverage hypotheses are testable perturbations, not prescriptions. Where demand-side behaviour is weakly visible, the correct move is observation — improving visibility before attempting change.
Structural resemblances · Clusters with similar stall configurations
A full ClusterOS diagnostic adds actor questionnaire data, working sessions, and anchor interviews — producing higher-confidence stall identification, board-ready stack analysis, and leverage hypotheses calibrated to your specific context.